Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-26

Clinical Trial Update: Efficacy and Tolerability of a Phytotherapy Combination (Aqualibra) in Patients With Uncomplicated Cystitis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and tolerability of a phytotherapy combination (Aqualibra) for uncomplicated cystitis, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aqualibra

Snippet

Sponsor: Medice Arzneimittel Pütter GmbH & Co KG | Conditions: Urinary Tract Infection Lower Acute | Phase 3 | Status: COMPLETED